D.E. Shaw & Co’s St Jude Medical STJ Stock Holding History

D.E. Shaw & Co’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-76,000	Closed	-$4.7M	–	4009
2015 Q4	$4.7M	Sell	76,000 -23,700	-24%	-$1.49M	0.01%	1454
2015 Q3	$6.29M	Hold	99,700	–	–	0.01%	1239
2015 Q2	$7.29M	Hold	99,700	–	–	0.01%	1212
2015 Q1	$6.52M	Sell	99,700 -34,200	-26%	-$2.27M	0.01%	1215
2014 Q4	$8.71M	Hold	133,900	–	–	0.01%	1196
2014 Q3	$8.05M	Hold	133,900	–	–	0.01%	1223
2014 Q2	$9.27M	Hold	133,900	–	–	0.01%	1152
2014 Q1	$8.76M	Buy	133,900 +47,500	+55%	+$3.09M	0.01%	1137
2013 Q4	$5.35M	Buy	86,400 +68,400	+380%	+$3.96M	0.01%	1618
2013 Q3	$966K	Buy	+18,000	New	+$927K	﹤0.01%	3071

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

D.E. Shaw & Co's STJ Position: Q1 2017 in Review

D.E. Shaw & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 21,204 shares — an estimated $1.7M sold.

D.E. Shaw & Co first reported a position in STJ in Q3 2013 and held it in 13 quarters. The position peaked at $113M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

D.E. Shaw & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
D.E. Shaw & Co sold 21,204 St Jude Medical shares in Q1 2017, an estimated $1.7M.
D.E. Shaw & Co first reported a position in St Jude Medical in Q3 2013 and held it in 13 quarters.
D.E. Shaw & Co's St Jude Medical position peaked at $113M in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.